Header Logo

Connection

John Zajecka to Antidepressive Agents

Back to Details
This is a "connection" page, showing publications John Zajecka has written about Antidepressive Agents.
John Zajecka
Connection Strength
3.438
Antidepressive Agents
  1. Evidence for the use of l-methylfolate combined with antidepressants in MDD. J Clin Psychiatry. 2011 Aug; 72(8):e25.
    View in: PubMed
    Score: 0.373
  2. Augmentation strategies to increase antidepressant tolerability. J Clin Psychiatry. 2007; 68 Suppl 10:23-7.
    View in: PubMed
    Score: 0.272
  3. SNRIs in the management of acute major depressive disorder. J Clin Psychiatry. 2004; 65 Suppl 17:11-8.
    View in: PubMed
    Score: 0.221
  4. Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series. J Clin Psychiatry. 2023 02 01; 84(2).
    View in: PubMed
    Score: 0.207
  5. Treating depression to remission. J Clin Psychiatry. 2003; 64 Suppl 15:7-12.
    View in: PubMed
    Score: 0.206
  6. Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin Psychiatry. 2001; 62 Suppl 3:35-43.
    View in: PubMed
    Score: 0.179
  7. Pharmacotherapy of depression and mixed states in bipolar disorder. J Affect Disord. 2000 Sep; 59 Suppl 1:S39-S56.
    View in: PubMed
    Score: 0.175
  8. Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial. JAMA Psychiatry. 2020 03 01; 77(3):237-245.
    View in: PubMed
    Score: 0.169
  9. Clinical issues in long-term treatment with antidepressants. J Clin Psychiatry. 2000; 61 Suppl 2:20-5.
    View in: PubMed
    Score: 0.167
  10. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2019 09 01; 76(9):893-903.
    View in: PubMed
    Score: 0.164
  11. Clinical management of antidepressant discontinuation. J Clin Psychiatry. 1997; 58 Suppl 7:37-40.
    View in: PubMed
    Score: 0.136
  12. Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull. 1997; 33(4):755-60.
    View in: PubMed
    Score: 0.136
  13. Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study. Neuropsychopharmacology. 2017 Mar; 42(4):844-853.
    View in: PubMed
    Score: 0.134
  14. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis. J Clin Psychiatry. 1995 Aug; 56(8):338-43.
    View in: PubMed
    Score: 0.123
  15. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014 Oct; 71(10):1157-64.
    View in: PubMed
    Score: 0.116
  16. Antidepressant drug fever. J Clin Psychopharmacol. 1991 Feb; 11(1):73-4.
    View in: PubMed
    Score: 0.090
  17. Antidepressant combination and potentiation. Psychiatr Med. 1991; 9(1):55-75.
    View in: PubMed
    Score: 0.090
  18. Innovative somatic treatments for depression. Psychiatr Med. 1991; 9(1):77-103.
    View in: PubMed
    Score: 0.090
  19. Coexisting major depression and obsessive-compulsive disorder treated with venlafaxine. J Clin Psychopharmacol. 1990 Apr; 10(2):152-3.
    View in: PubMed
    Score: 0.085
  20. Preventing recurrent depression: long-term treatment for major depressive disorder. J Clin Psychiatry. 2007 Mar; 68(3):e06.
    View in: PubMed
    Score: 0.069
  21. A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. J Clin Psychiatry. 2006 Nov; 67(11):1674-81.
    View in: PubMed
    Score: 0.067
  22. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol. 2003 May; 18(3):151-6.
    View in: PubMed
    Score: 0.053
  23. Setting Up a Successful Vagus Nerve Stimulation Service for Patients With Difficult-to-Treat Depression. Neuromodulation. 2022 Apr; 25(3):316-326.
    View in: PubMed
    Score: 0.048
  24. Management of comorbid anxiety and depression. J Clin Psychiatry. 1995; 56 Suppl 2:10-3.
    View in: PubMed
    Score: 0.030
  25. The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. J Psychiatr Res. 2011 Jan; 45(1):64-75.
    View in: PubMed
    Score: 0.022
  26. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005 Sep 01; 58(5):347-54.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.